Controlled intermittent chemotherapy with isoniazid and the second line preparations
Utkin, V.V.; Zhukova, G.N.; Shmeleva, V.I.
Problemy Tuberkuleza 6: 22-26
1975
ISSN/ISBN: 0032-9533 PMID: 1215343 Document Number: 85906
Document emailed within 1 workday
Related Documents
Iwainsky, H.; Eule, H.; Fischer, P.; Werner, E.; Winsel, K.; Franke, H. 1977: The different inactivation of isoniazid in intermittent chemotherapy Zeitschrift für Erkrankungen der Atmungsorgane 147(1): 41-50Rudoĭ, N.M.; Utkin, V.V.; Fedorova, I.E.; Afanas'eva, I.P. 1970: Restoration of drug sensitivity in Mycobacterium tuberculosis to streptomycin and isoniazid during treatment with preparations of the 1st series Antibiotiki 15(4): 355-357
Sternberg, C.N.; Yagoda, A.; Scher, H.I.; Whitmore, W.F.; Herr, H.W.; Morse, M.J.; Sogani, P.C.; Bosl, G.; Watson, R.C.; Hollander, P.S. 1988: Neo-adjuvant M-VAC chemotherapy trials in transitional cell carcinoma: perspectives for first line chemotherapy Progress in Clinical and Biological Research 260: 551-555
Inokuchi, M.; Yamashita, T.; Yamada, H.; Kojima, K.; Sekita, Y.; Kawano, T.; Sugihara, K. 2007: Second-line chemotherapy in gastric cancer following S-1 with CPT-11 chemotherapy performed as clinical trial Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(6): 875-879
Nagayama, N.; Shishido, Y.; Masuda, K.; Baba, M.; Tamura, A.; Nagai, H.; Akagawa, S.; Kawabe, Y.; Machida, K.; Kurashima, A.; Komatsu, H.; Yotsumoto, H. 2004: Leukopenia due to anti-tuberculous chemotherapy including rifampicin and isoniazid Kekkaku: 79(5): 341-348
Freerksen, E.; Alvarenga, A.E.; Leguizamon, O.; de Morra, M.V.; von Ballestrem, W.; Reyes, L.A. 1991: Short-term chemotherapy of leprosy using the combination rifampicin + cotrimoxazole + isoniazid Medizinische Klinik 86(9): 441-448
Milinder, N.M. 1977: Intravenous chemotherapy of destructive pulmonary tuberculosis using high doses of isoniazid Problemy Tuberkuleza 7: 51-54
Coury, C.; Constans, P.; Parrot, R.; Baron, A. 1970: Results of treatment with rifampicin-isoniazid in 100 tubercular patients with sensitive bacilli a 6 to 24 month controlled experiment Revue de Tuberculose et de Pneumologie 34(5): 688-697
Xiao, Y.-Y.; Zhan, P.; Yuan, D.-M.; Liu, H.-B.; Lv, T.-F.; Shi, Y.; Song, Y. 2013: Chemotherapy plus Vandetanib or chemotherapy alone in advanced non-small cell lung cancer: a meta-analysis of four randomised controlled trials Clinical Oncology 25(1): E7
Baba, H.; Shinkai, A.; Azuma, Y. 1979: Controlled clinical trial of three 6 month regimens of chemotherapy for pulmonary tuberculosis. (Report 2)--Results at one year after completing chemotherapy--(author's transl) Kekkaku: 54(1): 29-36
Königshausen, T.; Altrogge, D.; Hein, D.; Grabensee, B.; Pütter, J. 1978: Isoniazid elimination by means of hemodialysis and hemoperfusion in acute isoniazid poisoning Verhandlungen der Deutschen Gesellschaft für Innere Medizin 84: 1241-1244
Amlabu, V.; Mulligan, C.; Jele, N.; Evans, A.; Gray, D.; Zar, H.J.; McIlleron, H.; Smith, P. 2014: Isoniazid/acetylisoniazid urine concentrations: markers of adherence to isoniazid preventive therapy in children International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 18(5): 528-530
Belianin, I.I. 2004: Decreased resistance of multiresistant mycobacteria to isoniazid during the treatment of experimental tuberculosis with ozone and isoniazid Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2004(3): 95-98
Danková, D.; Drapela, J.; Krivánek, J. 1979: Intermittent chemotherapy of tuberculosis in Kolín District Problemy Tuberkuleza 10: 9-12
Shukiurov, S.Z.; Shmeleva, L.V.; Rakhmanova, R.A.; Agaeva, L.N.; Dzhamalova, E.D. 1978: Intermittent chemotherapy method in pulmonary tuberculosis Problemy Tuberkuleza 6: 20-24
Mthiyane, T.; Millard, J.; Adamson, J.; Balakrishna, Y.; Connolly, C.; Owen, A.; Rustomjee, R.; Dheda, K.; McIlleron, H.; Pym, A.S. 2020: N-Acetyltransferase 2 Genotypes among Zulu-Speaking South Africans and Isoniazid and N-Acetyl-Isoniazid Pharmacokinetics during Antituberculosis Treatment Antimicrobial Agents and ChemoTherapy 64(4)
Kucharz, E.J. 1995: Studies on immunomodulatory properties of isoniazid. Influence of isoniazid on responsiveness of peripheral blood mononuclear cells to interleukin-2 Central European Journal of Public Health 3(2): 65-66
Sasaki, Y.; Mochizuki, K.; Shigeto, E.; Konishiike, J. 1986: Present status and chemotherapy of extrapulmonary tuberculosis in national sanatoria--urinary tuberculosis. Report of the B series of 26th Controlled Trials of Chemotherapy--Cooperative Study Unit of Chemotherapy of Tuberculosis of National Sanatoria in Japan (CSUCTNS) Kekkaku: 61(1): 9-13
Fedotova, Z.N.; Gur'ian, I.E.; Kochetov, B.I. 1972: Primary drug resistance of Mycobacterium tuberculosis to 2d line preparations Problemy Tuberkuleza 50(11): 21-24
Stadler, A. 1992: Thermoformen : Mehrschichtoprodukte im In-line-und Halb-in-line-Verfahren - Thermoforming: multi-layer products produced by in-line and semi-in-line processes Plastverarbeiter 43(6): 110-113